Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119816098 | 11981609 | 8 | F | 20141106 | 20160629 | 20160131 | 20160701 | EXP | PHHY2014CA148782 | NOVARTIS | 77.13 | YR | M | Y | 0.00000 | 20160701 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119816098 | 11981609 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | 21008 | 30 | MG | /month | |||||||
| 119816098 | 11981609 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 119816098 | 11981609 | 3 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 2.5 MG, BID | 0 | 2.5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119816098 | 11981609 | 1 | Neuroendocrine tumour |
| 119816098 | 11981609 | 2 | Neuroendocrine tumour |
| 119816098 | 11981609 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119816098 | 11981609 | HO |
| 119816098 | 11981609 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119816098 | 11981609 | Asthenia | |
| 119816098 | 11981609 | Blood pressure diastolic decreased | |
| 119816098 | 11981609 | Blood pressure systolic increased | |
| 119816098 | 11981609 | Body temperature decreased | |
| 119816098 | 11981609 | Chills | |
| 119816098 | 11981609 | Decreased appetite | |
| 119816098 | 11981609 | Diabetes mellitus inadequate control | |
| 119816098 | 11981609 | Dysstasia | |
| 119816098 | 11981609 | Fatigue | |
| 119816098 | 11981609 | Flatulence | |
| 119816098 | 11981609 | Gastrointestinal disorder | |
| 119816098 | 11981609 | Hypoglycaemia | |
| 119816098 | 11981609 | Influenza like illness | |
| 119816098 | 11981609 | Malaise | |
| 119816098 | 11981609 | Nasopharyngitis | |
| 119816098 | 11981609 | Neuroendocrine tumour | |
| 119816098 | 11981609 | Pain | |
| 119816098 | 11981609 | Seizure | |
| 119816098 | 11981609 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119816098 | 11981609 | 1 | 20141106 | 0 | ||
| 119816098 | 11981609 | 2 | 20141106 | 0 |